U.S. Retinal Therapeutics Market
U.S. Retinal Therapeutics Market
RELEASE DATE
07-Jun-2011
07-Jun-2011
REGION
North America
North America
Research Code: N85D-01-00-00-00
SKU: HC02172-NA-MR_07791
$4,950.00
In stock
SKU
HC02172-NA-MR_07791
Description
This research service provides an indepth analysis of factors affecting the growth of the U.S. retinal therapeutics market over the period 2006-2016. Included are disease and treatment overviews, product analyses, patient forecasts, product revenue forecasts, and market share analyses. In this research service, the market is segmented by retinal disease: age-related macular degeneration (AMD), diabetic retinopathy (DR)/diabetic macular edema (DME), and both branch and central retinal vein occlusion (BRVO/CRVO). Major market challenges, drivers, and restraints are identified and discussed. Additionally, a pipeline of compounds making their way through clinical trials is presented in the "Product Pipeline" section of this research service.
Table of Contents
U.S. Retinal Therapeutics Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Introduction
- Disease Overviews
Clinical Need and Burden of Disease
- Age-related Macular Degeneration
- Diabetic Retinopathy and Diabetic Macular Edema
- Retinal Vein Occlusion
Market Trends
- Market Engineering Measurements
- Industry Challenges and Strategies
- Market Drivers
Treatment Overview
Product Pipeline
Market Outlook and Revenue Forecasts
Competitive Overview
Decision Support Databases
Popular Topics
This research service provides an indepth analysis of factors affecting the growth of the U.S. retinal therapeutics market over the period 2006-2016. Included are disease and treatment overviews, product analyses, patient forecasts, product revenue forecasts, and market share analyses. In this research service, the market is segmented by retinal disease: age-related macular degeneration (AMD), diabetic retinopathy (DR)/diabetic macular edema (DME), and both branch and central retinal vein occlusion (BRVO/CRVO). Major market challenges, drivers, and restraints are identified and discussed. Additionally, a pipeline of compounds making their way through clinical trials is presented in the 'Product Pipeline' section of this research service.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N85D-01-00-00-00 |
Is Prebook | No |